Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.

Srivastava SK, Ramana KV, Bhatnagar A.

Endocr Rev. 2005 May;26(3):380-92. Epub 2005 Apr 6. Review.

PMID:
15814847
2.

Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells.

Ramana KV, Friedrich B, Bhatnagar A, Srivastava SK.

FASEB J. 2003 Feb;17(2):315-7. Epub 2002 Dec 17.

PMID:
12490536
3.

Role of nitric oxide in regulating aldose reductase activation in the ischemic heart.

Kaiserova K, Tang XL, Srivastava S, Bhatnagar A.

J Biol Chem. 2008 Apr 4;283(14):9101-12. doi: 10.1074/jbc.M709671200. Epub 2008 Jan 27.

4.

Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.

Tammali R, Saxena A, Srivastava SK, Ramana KV.

Endocrinology. 2010 May;151(5):2140-50. doi: 10.1210/en.2010-0160. Epub 2010 Mar 22.

5.

Aldose reductase prevents aldehyde toxicity in cultured human lens epithelial cells.

Pladzyk A, Ramana KV, Ansari NH, Srivastava SK.

Exp Eye Res. 2006 Aug;83(2):408-16. Epub 2006 Apr 24.

PMID:
16631166
6.

Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells.

Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK.

J Biol Chem. 2002 Aug 30;277(35):32063-70. Epub 2002 Jun 12.

7.

Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells.

Pladzyk A, Reddy AB, Yadav UC, Tammali R, Ramana KV, Srivastava SK.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5395-403.

PMID:
17122129
8.

Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury.

Ruef J, Liu SQ, Bode C, Tocchi M, Srivastava S, Runge MS, Bhatnagar A.

Arterioscler Thromb Vasc Biol. 2000 Jul;20(7):1745-52.

9.

From a dull enzyme to something else: facts and perspectives regarding aldose reductase.

Del Corso A, Cappiello M, Mura U.

Curr Med Chem. 2008;15(15):1452-61. Review.

PMID:
18537622
10.

Aldose reductase inhibitors.

Oka M, Kato N.

J Enzyme Inhib. 2001 Dec;16(6):465-73. Review.

PMID:
12164386
11.
12.

Recent studies of aldose reductase enzyme inhibition for diabetic complications.

Suzen S, Buyukbingol E.

Curr Med Chem. 2003 Aug;10(15):1329-52. Review.

PMID:
12871133
13.

Regulation of vascular smooth muscle cell growth by aldose reductase.

Bhatnagar A, Ruef J, Liu S, Srivastava S, Srivastava SK.

Chem Biol Interact. 2001 Jan 30;130-132(1-3):627-36.

PMID:
11306081
14.

Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.

Obrosova IG, Minchenko AG, Vasupuram R, White L, Abatan OI, Kumagai AK, Frank RN, Stevens MJ.

Diabetes. 2003 Mar;52(3):864-71.

15.

Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.

Srivastava S, Ramana KV, Tammali R, Srivastava SK, Bhatnagar A.

Diabetes. 2006 Apr;55(4):901-10.

16.

Aldose reductase mediates the mitogenic signals of cytokines.

Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Srivastava SK.

Chem Biol Interact. 2003 Feb 1;143-144:587-96.

PMID:
12604244
17.

Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.

Chandra D, Jackson EB, Ramana KV, Kelley R, Srivastava SK, Bhatnagar A.

Diabetes. 2002 Oct;51(10):3095-101.

18.

Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.

Saxena A, Shoeb M, Ramana KV, Srivastava SK.

Eur J Cancer. 2013 Oct;49(15):3311-9. doi: 10.1016/j.ejca.2013.05.031. Epub 2013 Jul 1.

19.

Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.

Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK.

Diabetes. 2004 Nov;53(11):2910-20.

20.

Contributions of polyol pathway to oxidative stress in diabetic cataract.

Lee AY, Chung SS.

FASEB J. 1999 Jan;13(1):23-30.

PMID:
9872926

Supplemental Content

Support Center